<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951390</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2016/0440</org_study_id>
    <nct_id>NCT02951390</nct_id>
  </id_info>
  <brief_title>High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome.</brief_title>
  <acronym>EndoLynch</acronym>
  <official_title>High Definition White-Light Colonoscopy Versus Chromoendoscopy for Surveillance of Lynch Syndrome. A Prospective, Multicenter and Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fundacion Clinic per a la Recerca Biomédica</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Adenomas in Lynch syndrome have an accelerated progression to colorectal cancer (CRC) which
      might occur despite a regular follow-up. Despite low evidence, high-definition technology
      (HD) and indigo-carmine chromoendoscopy (CE) are recommended for surveillance in Lynch
      syndrome.The investigators will conduct a prospective multicenter randomized non-inferiority
      study. The principal aim is to compare the adenoma detection rate with WLE vs CE. Our
      hypothesis is that HD-white-light endoscopy (WLE) is not inferior to CE. Therefore - under
      expert hands - HD-CE does not add any significant advantage over HD-WLE on adenoma detection
      rate in patients with Lynch syndrome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will conduct a prospective multicenter randomized non-inferiority study.
      Eligible patients will be those with Lynch syndrome (known germline mutation in mismatch
      repair genes) who undergo surveillance colonoscopies. Patients will be sequentially assigned
      in a 1:1 ratio to HD-WLE or HD-CE. The method of stratified randomization based on partial
      colectomy history will be used to avoid proportion imbalance between groups. Participant
      centers must have an organized high-risk of CRC clinic and endoscopic unit provided with HD
      technology. Endoscopists must have a documented high adenoma detection rate and experience in
      performing CE in patients with high-risk conditions of CRC.

      The principal aim is to compare the adenoma detection rate with WLE vs CE. Principal outcome
      measures will be: 1) adenoma detection rate, defined as the proportion of patients with at
      least one adenoma in each arm; 2) number of adenomas per patient, defined as the total number
      of detected adenomas in each arm (HD-WLE or HD-CE) divided by the number of colonoscopies in
      each arm.

      The sample size calculation was determined for a non-inferiority study. Assuming an ADR of
      28% with conventional chromoendoscopy in patients with Lynch syndrome, a 15% non-inferiority
      margin, a one-sided significance level of 0.05 powered at 80% and a 10% of drop-off. Based on
      these assumptions, it was determined that 122 patients were required for each arm (a total of
      244).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adenoma detection rate</measure>
    <time_frame>one year</time_frame>
    <description>Adenoma detection rate is defined as the proportion of patients with at least one adenoma in each arm</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean of adenomas per patient</measure>
    <time_frame>one year</time_frame>
    <description>the total number of adenomas detected in each group (HD-WLE or HD-CE) divided by the number of colonoscopies in each group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number per patient of total polyps</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number per patient of total serrated lesions</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Polyp detection rate</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serrated lesions detection rate</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time</measure>
    <time_frame>30 minutes</time_frame>
    <description>Extubation time from the cecum to scope removal from the anus, with exception of time taken for any therapeutic intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total procedure time</measure>
    <time_frame>30 minutes</time_frame>
    <description>Starting with endoscope insertion and withdrawal time including therapeutic interventions</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Lynch Syndrome</condition>
  <arm_group>
    <arm_group_label>High-definition white-light endoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High-definition white-light endoscopy without indigo carmine instilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-definition chromoendoscopy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>High-definition indigo-carmine chromoendoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High-definition white-light endoscopy</intervention_name>
    <description>The intervention is do not perform chromoendoscopy</description>
    <arm_group_label>High-definition white-light endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with proven pathologic germline mutation in one of the mismatch-repair (MMR)
             gene (MLH1, MSH2, MSH6, PMS2 or Epcam) who will undergo surveillance colonoscopy

        Exclusion Criteria:

          -  Patients with total colectomy

          -  Concomitant inflammatory bowel disease

          -  Inadequate bowel preparation (Boston scale &lt;2 in any colonic segment)

          -  Incomplete procedure (without intubation of cecum or ileo-colonic anastomosis)

          -  Previous colonoscopy in less than one year

          -  Inability to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>María Pellisé, MD. PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Clinic of Barcelona</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>María Pellisé. MD. PhD.</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Hurlstone DP, Karajeh M, Cross SS, McAlindon ME, Brown S, Hunter MD, Sanders DS. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective &quot;back-to-back&quot; endoscopic study. Am J Gastroenterol. 2005 Oct;100(10):2167-73.</citation>
    <PMID>16181364</PMID>
  </reference>
  <reference>
    <citation>Lecomte T, Cellier C, Meatchi T, Barbier JP, Cugnenc PH, Jian R, Laurent-Puig P, Landi B. Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol. 2005 Sep;3(9):897-902.</citation>
    <PMID>16234028</PMID>
  </reference>
  <reference>
    <citation>Stoffel EM, Turgeon DK, Stockwell DH, Zhao L, Normolle DP, Tuck MK, Bresalier RS, Marcon NE, Baron JA, Ruffin MT, Brenner DE, Syngal S; Great Lakes-New England Clinical Epidemiology and Validation Center of the Early Detection Research Network. Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila). 2008 Nov;1(6):470-5. doi: 10.1158/1940-6207.CAPR-08-0098.</citation>
    <PMID>19138994</PMID>
  </reference>
  <reference>
    <citation>Hüneburg R, Lammert F, Rabe C, Rahner N, Kahl P, Büttner R, Propping P, Sauerbruch T, Lamberti C. Chromocolonoscopy detects more adenomas than white light colonoscopy or narrow band imaging colonoscopy in hereditary nonpolyposis colorectal cancer screening. Endoscopy. 2009 Apr;41(4):316-22. doi: 10.1055/s-0028-1119628. Epub 2009 Apr 1.</citation>
    <PMID>19340735</PMID>
  </reference>
  <reference>
    <citation>Rahmi G, Lecomte T, Malka D, Maniere T, Le Rhun M, Guimbaud R, Lapalus MG, Le Sidaner A, Moussata D, Caron O, Barbieux JP, Gaudric M, Coron E, Barange K, Ponchon T, Sautereau D, Samaha E, Saurin JC, Chaussade S, Laurent-Puig P, Chatellier G, Cellier C. Impact of chromoscopy on adenoma detection in patients with Lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study. Am J Gastroenterol. 2015 Feb;110(2):288-98. doi: 10.1038/ajg.2014.423. Epub 2015 Jan 20.</citation>
    <PMID>25601014</PMID>
  </reference>
  <reference>
    <citation>Rondagh EJ, Gulikers S, Gómez-García EB, Vanlingen Y, Detisch Y, Winkens B, Vasen HF, Masclee AA, Sanduleanu S. Nonpolypoid colorectal neoplasms: a challenge in endoscopic surveillance of patients with Lynch syndrome. Endoscopy. 2013;45(4):257-64. doi: 10.1055/s-0032-1326195. Epub 2013 Feb 25.</citation>
    <PMID>23440588</PMID>
  </reference>
  <reference>
    <citation>Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut. 1992 Jun;33(6):783-6.</citation>
    <PMID>1624160</PMID>
  </reference>
  <reference>
    <citation>Rijcken FE, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut. 2002 Mar;50(3):382-6.</citation>
    <PMID>11839719</PMID>
  </reference>
  <reference>
    <citation>Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut. 2002 Feb;50(2):228-34. Erratum in: Gut 2002 May;50(5):742.</citation>
    <PMID>11788565</PMID>
  </reference>
  <reference>
    <citation>Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Sampson JR, Capella G, Mecklin JP, Möslein G; Mallorca Group (http://mallorca-group.eu). Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017 Mar;66(3):464-472. doi: 10.1136/gutjnl-2015-309675. Epub 2015 Dec 9.</citation>
    <PMID>26657901</PMID>
  </reference>
  <reference>
    <citation>Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997 Jan;112(1):24-8.</citation>
    <PMID>8978338</PMID>
  </reference>
  <reference>
    <citation>van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. Review.</citation>
    <PMID>16454841</PMID>
  </reference>
  <reference>
    <citation>Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ; American Society of Clinical Oncology; European Society of Clinical Oncology. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J Clin Oncol. 2015 Jan 10;33(2):209-17. doi: 10.1200/JCO.2014.58.1322. Epub 2014 Dec 1.</citation>
    <PMID>25452455</PMID>
  </reference>
  <reference>
    <citation>Balmaña J, Balaguer F, Cervantes A, Arnold D; ESMO Guidelines Working Group. Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2013 Oct;24 Suppl 6:vi73-80. doi: 10.1093/annonc/mdt209. Epub 2013 Jun 27.</citation>
    <PMID>23813931</PMID>
  </reference>
  <reference>
    <citation>Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A, Dekker E, Sanduleanu S, Poley JW, Hardwick JC, de Vos Tot Nederveen Cappel WH, van der Meulen-de Jong AE, Tan TG, Jacobs MA, Mohamed FL, de Boer SY, van de Meeberg PC, Verhulst ML, Salemans JM, van Bentem N, Westerveld BD, Vecht J, Nagengast FM. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology. 2010 Jun;138(7):2300-6. doi: 10.1053/j.gastro.2010.02.053. Epub 2010 Mar 2.</citation>
    <PMID>20206180</PMID>
  </reference>
  <reference>
    <citation>Kamiński MF, Hassan C, Bisschops R, Pohl J, Pellisé M, Dekker E, Ignjatovic-Wilson A, Hoffman A, Longcroft-Wheaton G, Heresbach D, Dumonceau JM, East JE. Advanced imaging for detection and differentiation of colorectal neoplasia: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2014 May;46(5):435-49. doi: 10.1055/s-0034-1365348. Epub 2014 Mar 17.</citation>
    <PMID>24639382</PMID>
  </reference>
  <reference>
    <citation>Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol. 2007 Apr;102(4):856-61. Epub 2007 Jan 11.</citation>
    <PMID>17222317</PMID>
  </reference>
  <reference>
    <citation>Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011 Jan;9(1):42-6. doi: 10.1016/j.cgh.2010.09.013. Epub 2010 Oct 1.</citation>
    <PMID>20888435</PMID>
  </reference>
  <reference>
    <citation>Hazewinkel Y, López-Cerón M, East JE, Rastogi A, Pellisé M, Nakajima T, van Eeden S, Tytgat KM, Fockens P, Dekker E. Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imaging. Gastrointest Endosc. 2013 Jun;77(6):916-24. doi: 10.1016/j.gie.2012.12.018. Epub 2013 Feb 21.</citation>
    <PMID>23433877</PMID>
  </reference>
  <reference>
    <citation>Kahi CJ, Li X, Eckert GJ, Rex DK. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc. 2012 Mar;75(3):515-20. doi: 10.1016/j.gie.2011.08.021. Epub 2011 Oct 21.</citation>
    <PMID>22018551</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 28, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>María Pellisé</investigator_full_name>
    <investigator_title>MD. PhD. Consultant</investigator_title>
  </responsible_party>
  <keyword>Surveillance</keyword>
  <keyword>Colorectal cancer</keyword>
  <keyword>Colonoscopy</keyword>
  <keyword>Adenoma</keyword>
  <keyword>Chromoendoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Colorectal Neoplasms, Hereditary Nonpolyposis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

